financetom
Business
financetom
/
Business
/
Pet foods startup Dogsee Chew raises Rs 50 crore from Mankind Pharma, Sixth Sense Ventures
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pet foods startup Dogsee Chew raises Rs 50 crore from Mankind Pharma, Sixth Sense Ventures
Jan 20, 2022 4:56 AM

Pet foods startup Dogsee Chew on Wednesday said it has raised Rs 50 crore in Series A round from Mankind Pharma along with existing investor, Sixth Sense Ventures. The investment in the firm that offers 100 percent vegetarian dog treats marks Mankind Pharma's entry into the pet food category, Dogsee Chew said in a statement.

Share Market Live

NSE

Sixth Sense Ventures had also earlier participated in the company's pre-series A funding in November 2021, it added. The funds will be primarily used towards brand building, R&D, and building a strong distribution network, the company said, adding it currently exports its products to over 30 countries.

Also Read

| NFT marketplace Diginoor raises $1 million in seed funding

Commenting on the fundraise, Dogsee Chew Founder Bhupendra Khanal said, "Mankind Pharma has an established history of creating highly successful consumer products. Having the backing of such a giant is a huge vote of confidence for us and we look forward to learning from their expertise."

On its investment, Mankind Pharma Chief Operations Officer Arjun Juneja said, "The trust that people have shown in Dogsee Chew has strengthened our confidence to invest in a brand that is true to its nature. Mankind has always believed in innovation and, with brands like Dogsee Chew that are innovative and young, we see the future of India."

First Published:Jan 20, 2022 1:56 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved